Analyst Ratings for Tranzyme (TZYM)
TZYM Rating Summary
TZYM Price Target Summary
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$4.83 (+705.6%)
Avg. $ Target:
$4.83 (+705.6%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 11/16/2012 | Canaccord Genuity | Downgrade | Hold (Buy) |
1.50 (N/A) |
0.95 | 0.60 | -36.84% | Details |
| 11/15/2012 | JMP Securities | Downgrade | Market Perform (Market Outperform) |
N/A (N/A) |
1.40 | 0.60 | -57.14% | Details |
| 11/15/2012 | Stifel Nicolaus | Downgrade | Hold (Buy) |
N/A (N/A) |
1.40 | 0.60 | -57.14% | Details |
| 7/31/2012 | Cowen | New Coverage | Outperform (N/A) |
N/A (N/A) |
4.01 | 0.60 | -85.04% | Details |
| 3/13/2012 | BMO Capital | New Coverage | Outperform (N/A) |
6.00 (N/A) |
2.90 | 0.60 | -79.31% | Details |
| 5/13/2011 | Citi | New Coverage | Buy (N/A) |
N/A (N/A) |
4.06 | 0.60 | -85.22% | Details |
